Abbott bolsters diagnostics portfolio with up to $23 billion buyout of Exact Sciences ⊖
Abbott said on Thursday it would buy cancer test maker Exact Sciences in an up to $23 billion deal, bolstering the medical device maker's diagnostics business.
You are not logged in so some information on this page has been withheld. To see more, please log in or sign up.